Learn more

ACROVIS BIOSTRUCTURES GMBH

Overview
  • Total Patents
    11
About

ACROVIS BIOSTRUCTURES GMBH has a total of 11 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Germany and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ADIPHARM EAD, RECORDATI IND CHIMICA E FARMACEUTICA S P A and OOO KONSORTSIUM PIK.

Patent filings in countries

World map showing ACROVIS BIOSTRUCTURES GMBHs patent filings in countries

Patent filings per year

Chart showing ACROVIS BIOSTRUCTURES GMBHs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Diesinger Torsten Dr 8
#2 Haehner Thomas Dr 8
#3 Diesinger Torsten 3
#4 Haehner Thomas 2

Latest patents

Publication Filing date Title
DE102012018052A1 Pharmaceutical combination preparation
DE102011112103A1 Composition, useful as antineoplastic drug, comprises a cyclodextrin complex with 12-imidazolyl-1-dodecanol
DE102010012233A1 New substituted imidazole compounds, useful e.g. to treat cancer, pathological consequences of alcohol abuse, viral hepatitis, acute and chronic pancreatitis, toxic renal disease and hepatic insulin resistance in diabetes mellitus
DE102010012232A1 New imidazole useful in pharmaceutical preparation e.g. for prevention or treatment of cancer diseases, pathological effects of alcohol misuse, viral hepatitis, steatohepatitis, acute and chronic pancreatitis, toxic renal diseases
DE102010012225A1 Cosmetics, useful for skin care and for prophylaxis and treatment of photodamaged skin and age-damaged skin, preferably for prophylactic treatment of wrinkles and skin roughness, comprise 12-imidazolyl-1-dodecanol
DE102010012235A1 New substituted imidazole compounds, useful e.g. to treat cancer, pathological consequences of alcohol abuse, viral hepatitis, acute and chronic pancreatitis, toxic renal disease and hepatic insulin resistance in diabetes mellitus
DE102010012224A1 Pharmaceutical preparation, useful for the intravenous treatment of paracetamol intoxication, comprises 12-imidazolyl-1-dodecanol or its salt
DE102010012223A1 Pharmaceutical preparation, useful for the treatment of autoimmune disease, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, Crohn's disease or ulcerative colitis, comprises 12-imidazolyl-1-dodecanol
DE102010012226A1 Pharmaceutical combination preparation, useful to improve the effect of ursodeoxycholic acid, which is useful to treat e.g. nonalcoholic-steatohepatitis and viral hepatitis, comprises 12-imidazolyl-1-dodecanol and ursodeoxycholic acid
DE102010012234A1 Pharmaceutical combination preparation, useful to treat cancer, preferably to reduce e.g. nephrotoxicity of cisplatin or platinum complex analog, comprises 12-imidazolyl-1-dodecanol and cisplatin or a platinum complex analog